Trade

with

RTI Surgical Inc
(NASDAQ: RTIX)
AdChoices
3.56
-0.08
-2.20%
After Hours :
3.56
0.00
0.00%

Open

3.65

Previous Close

3.64

Volume (Avg)

286.36k (183.17k)

Day's Range

3.54-3.67

52Wk Range

2.77-5.58

Market Cap.

202.26M

Dividend Rate ( Yield )

-

Beta

1.54

Shares Outstanding

56.81M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 197.98M

    • Net Income

    • -17.81M

    • Market Cap.

    • 202.26M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -7.91

    • PEG (Price/Earnings Growth) Ratio

    • 1.49

    • Beta

    • 1.54

    • Forward P/E

    • 22.27

    • Price/Sales

    • 0.85

    • Price/Book Value

    • 1.77

    • Price/Cash flow

    • -588.24

      • EBITDA

      • -16.18M

      • Return on Capital %

      • -6.29

      • Return on Equity %

      • -12.76

      • Return on Assets %

      • -6.29

      • Book Value/Share

      • 2.05

      • Shares Outstanding

      • 56.81M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 6.43

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.16

        • Cashflow Estimate

        • 0.30

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 56.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 6.19

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.53

            • 64.08

            • Pre-Tax Margin

            • -10.58

            • 15.19

            • Net Profit Margin

            • -7.91

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 45.30

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -14.50

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -14.90

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.60

              • 0.34

              • Current Ratio

              • 3.47

              • 2.55

              • Quick Ratio

              • 0.92

              • 1.83

              • Interest Coverage

              • -18.43

              • 11.70

              • Leverage Ratio

              • 3.19

              • 1.86

              • Book Value/Share

              • 2.05

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -10.74

                • 34.72

                • P/E Ratio 5-Year High

                • -16.46

                • 224.03

                • P/E Ratio 5-Year Low

                • -5.96

                • 60.23

                • Price/Sales Ratio

                • 0.85

                • 3.22

                • Price/Book Value

                • 1.77

                • 3.26

                • Price/Cash Flow Ratio

                • -588.24

                • 18.80

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -12.76

                        (-11.60)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -6.29

                        (-8.40)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -9.75

                        (-10.90)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 1.48

                      • 2.77

                      • Asset Turnover

                      • 0.80

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -28.66M
                      Operating Margin
                      -14.47
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -588.24
                      Ownership

                      Institutional Ownership

                      68.30%

                      Top 10 Institutions

                      42.43%

                      Mutual Fund Ownership

                      21.79%

                      Float

                      98.09%

                      5% / Insider Ownership

                      2.40%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Russell US Small Cap Equity Fund

                      •  

                        1,138,316

                      • 0.00

                      • 2.00

                      • Vanguard Total Stock Mkt Idx

                      •  

                        887,197

                      • 0.00

                      • 1.56

                      • iShares Russell 2000 (AU)

                      •  

                        883,814

                      • -1.02

                      • 1.17

                      • DFA US Small Cap Value II Portfolio

                      •  

                        699,904

                      • 0.00

                      • 1.23

                      • Royce Opportunity Fund

                      •  

                        675,648

                      • -23.65

                      • 1.19

                      • Vanguard Extended Market Index Fund

                      •  

                        495,365

                      • 1.48

                      • 0.87

                      • Royce Micro Cap Series Fund

                      •  

                        461,500

                      • 0.00

                      • 0.81

                      • Legg Mason Royce US Small Cap Opp

                      •  

                        446,500

                      • -0.78

                      • 0.79

                      • Pru Ret Small Cap Value/Kennedy SP

                      •  

                        404,684

                      • 11.69

                      • 0.71

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        383,763

                      • 0.00

                      • 0.68

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Paradigm Capital Management, Inc.

                      •  

                        4,862,300

                      • +0.81%

                      • 8.56

                      • Dimensional Fund Advisors, Inc.

                      •  

                        3,186,262

                      • +2.97%

                      • 5.61

                      • BlackRock Fund Advisors

                      •  

                        2,915,370

                      • -13.82%

                      • 5.13

                      • Royce & Associates, LLC

                      •  

                        2,234,448

                      • -1.26%

                      • 3.93

                      • Tamarack Capital Management, LLC

                      •  

                        2,150,000

                      • +7.50%

                      • 3.78

                      • Gagnon Securities LLC

                      •  

                        1,943,522

                      • -1.47%

                      • 3.42

                      • Kopp Investment Advisors LLC

                      •  

                        1,888,917

                      • -7.81%

                      • 3.32

                      • Rock Springs Capital Management LP

                      •  

                        1,750,000

                      • +154.96%

                      • 3.08

                      • Russell Frank Co

                      •  

                        1,618,833

                      • -7.50%

                      • 2.85

                      • Vanguard Group, Inc.

                      •  

                        1,559,773

                      • +2.39%

                      • 2.75

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Distressed

                      Style

                      Small Growth

                      RTI Surgical Inc, formerly RTI Biologics, Inc., was incorporated in 1997 in Florida as a wholly-owned subsidiary of the University of Florida Tissue Bank. The Company process donated human musculoskeletal and other tissue, including ...morebone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing proprietary BIOCLEANSE®, TUTOPLAST® and CANCELLE™ SP sterilization processes and manufacture metal and synthetic implants for distribution to hospitals and surgeons. The Company process tissue at two facilities in Alachua, Florida and one facility in Neunkirchen, Germany, and manufacture metal and synthetic implants in Marquette, Michigan and Greenville, North Carolina. The Company distributes ...moreits implants and services in all 50 states and in over 45 countries. Its lines of business are comprised primarily of six categories: spine, sports medicine, surgical specialties, bone graft substitutes and general orthopedic, dental and ortho fixation. It has developed and utilized in the United States the patented BioCleanse® tissue sterilization process, which is an automated, pharmaceutical grade chemical sterilization process for musculoskeletal bone and certain soft tissue. The TUTOPLAST® tissue sterilization process utilizes solvent dehydration and chemical inactivation to remove blood, lipids and extraneous materials, and inactivate viruses and break down RNA and DNA into fragments not capable of replication and disease transmission while preserving the biological and mechanical properties. DBM-based pastes and putties are sterilized through the CANCELLE™ SP process, which is designed to preserve protein activity. The Company’s competitors in the conventional allograft market include the Musculoskeletal Transplant Foundation (“MTF”), AlloSource, LifeCell, Inc., a subsidiary of Kinetic Concepts Inc. and LifeNet. Among its competitors in precision machined allograft are MTF, LifeNet and AlloSource. Other companies who process and distribute allograft pastes include Medtronic, AlloSource, Integra, Wright and MTF. Companies who process and distribute xenograft tissue include Synovis, LifeCell, Cook Surgical and Medtronic. The Company considers its competitors in the metal and synthetic markets to include Alphatec, Globus Medical, Inc. (Globus), NuVasive, Inc. (NuVasive) and Orthofix. The Company is subject to federal, state and foreign laws and regulations.lessless

                      Key People

                      Brian K. Hutchison

                      CEO/Director/President

                      Dean H. Bergy

                      Chairman of the Board/Director

                      Mr. Robert P. Jordheim

                      CFO/Chief Accounting Officer/Executive VP

                      Roger W. Rose

                      Executive VP, Geographical/Other Executive Officer/President, Divisional

                      Thomas F. Rose

                      COO/Executive VP, Divisional/Secretary

                      • RTI Surgical Inc

                      • 11621 Research Circle

                      • Alachua, FL 32615

                      • USA.Map

                      • Phone: +1 386 418-8888

                      • Fax: +1 386 418-0342

                      • rtix.com

                      Incorporated

                      1997

                      Employees

                      1,100

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: